This study will be conducted to investigated the effect of decreased kidney function on PK and safety of GZR4 and to guide dosing recommendations in people with kidney impairment.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
16
single dose
Site 1
Suzhou, Jiangsu, China
AUC0-inf
Time frame: Day1-Day29
AUC0-last
Time frame: Day1-Day29
Cmax
Time frame: Day1-Day29
Incidence of TEAE
Time frame: Day1-Day29
AUC0-168h
Time frame: Day1-Day29
Tmax
Time frame: Day1-Day29
T1/2
Time frame: Day1-Day29
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.